1. Home
  2. AZTR vs UCAR Comparison

AZTR vs UCAR Comparison

Compare AZTR & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.23

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

Logo U Power Limited

UCAR

U Power Limited

HOLD

Current Price

$1.40

Market Cap

3.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTR
UCAR
Founded
2014
2013
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Auto Dealers and Gas Stations
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.1M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
AZTR
UCAR
Price
$0.23
$1.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.00
$50.00
AVG Volume (30 Days)
465.0K
5.7M
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
5.06
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.04
52 Week High
$1.40
$4.98

Technical Indicators

Market Signals
Indicator
AZTR
UCAR
Relative Strength Index (RSI) 51.64 48.58
Support Level $0.21 $1.29
Resistance Level $0.26 $1.71
Average True Range (ATR) 0.02 0.29
MACD -0.00 -0.06
Stochastic Oscillator 44.70 4.97

Price Performance

Historical Comparison
AZTR
UCAR

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

Share on Social Networks: